Apologies for the radio silence over the past 18 months. My work life took an interesting turn and I’ve been swamped ever since setting up both a new venture capital firm and a new TechBio startup. I’m back blogging now, and from a different perspective – no longer just a retained adviser, interim CBO or board member for startups, but also a startup CEO and venture investor.
Continue reading “New chapter in my career”Bioscience and Healthcare Megatrends that Startups Cannot Ignore
Does your startup ride a megatrend? When evaluating a bioscience startup, my first filter is often whether that aspiring business will exploit one of the megatrends sweeping through the bioscience and healthcare sector.
Continue reading “Bioscience and Healthcare Megatrends that Startups Cannot Ignore”Two Common Business Model Misconceptions
This blog post highlights two common misconceptions that bioscience startups often have with respect to their new venture’s business models. These misconceptions can lead to poor decisions that result, at best, in resource-wasting delays before a self-sustaining enterprise is established, and at worst, in their venture’s premature demise.
Continue reading “Two Common Business Model Misconceptions”